{"title":"cost-consequence分析双重和三重疗法治疗慢性肝炎的C类基因型1 naï成人患者同po—纤维化F2","authors":"R. Ravasio, R. Tomić, B. Deodato, R. Bruno","doi":"10.1007/S40276-013-0010-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":187376,"journal":{"name":"PharmacoEconomics Italian Research Articles","volume":"41 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Analisi di cost-consequence della duplice e triplice terapia nel trattamento dell’epatite cronica di tipo C genotipo 1 in pazienti adulti naïve con fibrosi F0–F2\",\"authors\":\"R. Ravasio, R. Tomić, B. Deodato, R. Bruno\",\"doi\":\"10.1007/S40276-013-0010-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":187376,\"journal\":{\"name\":\"PharmacoEconomics Italian Research Articles\",\"volume\":\"41 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PharmacoEconomics Italian Research Articles\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/S40276-013-0010-6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Italian Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/S40276-013-0010-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Analisi di cost-consequence della duplice e triplice terapia nel trattamento dell’epatite cronica di tipo C genotipo 1 in pazienti adulti naïve con fibrosi F0–F2